ISIS was so far our main focus for impetus from the US.
ANP's three drug developments with their multiple trial directions were seen to be " vulnerable " to the upswing from the US partner/ parent.
Today's news put another US influence on the map and I would suggest that US investors will not miss this.
ISIS' drug developments have not escaped the likes of GSK and Biogen ( nor the wider biotech investment community, see near daily rises for ISIS provided by Itsa ) and I believe that our more than obvious connection to Pfizer through Somavert will attract overseas money into ANP.
At what particular point remains to be seen but I would speculate that US biotech investors are a lot faster to catch on with industry developments than our domestic market.
To argue that only next year will give us some results from only phase 2 trials is shortsighted.
Other large pharmas have partnered with ISIS during phase 1 and phase 2 trials and I see our ATL1103 as not being different.
Today's market reaction was very short term driven without a deeper analysis of the content of today's ann.
I would expect market to realise the dimensions of our outlook to a greater degree in the days and weeks to come.
Perfect timing for those who research this properly to get set.
Next announcement prior to the onset of phase 2 trials should see details of our partnering/ licensing deal and days below 2 cents will not be seen again.
This, to me, is a certainty.
- Forums
- ASX - By Stock
- PER
- atl1103 development update
atl1103 development update, page-55
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
0.002(2.50%) |
Mkt cap ! $73.92M |
Open | High | Low | Value | Volume |
8.0¢ | 8.2¢ | 7.9¢ | $16.80K | 210.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 24999 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.3¢ | 31992 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24999 | 0.079 |
2 | 60000 | 0.078 |
2 | 114144 | 0.077 |
2 | 46800 | 0.075 |
1 | 100000 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.083 | 31992 | 1 |
0.084 | 100000 | 1 |
0.085 | 136669 | 3 |
0.086 | 33375 | 2 |
0.087 | 531562 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |